SEC Form 4 · accession 0001246360-15-001055
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J OConnell
Officer — EVP & GroupPres Restora Therap
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 3:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 18, 2015 | M | 18,723 | $36.24 | A | 113,844 | D | |
| Ordinary SharesF2 | Feb 18, 2015 | S | 20,570 | $78.2845 | D | 93,274 | D | |
| Ordinary Shares | Feb 19, 2015 | M | 14,390 | $36.24 | A | 107,664 | D | |
| Ordinary Shares | Feb 19, 2015 | M | 15,401 | $48.70 | A | 123,065 | D | |
| Ordinary SharesF3 | Feb 19, 2015 | S | 29,791 | $78.1697 | D | 93,274 | D | |
| Ordinary Shares | holding | — | — | — | 2,654 | I | ESOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $36.24 | Feb 18, 2015 | M | 18,723 | D | Oct 27, 2009 | Oct 27, 2018 | Ordinary Shares | 18,723 | 14,390 | D |
| Employee Stock Option (right to buy)F1 | $36.24 | Feb 19, 2015 | M | 14,390 | D | Oct 27, 2009 | Oct 27, 2018 | Ordinary Shares | 14,390 | 0 | D |
| Employee Stock Option (right to buy)F1 | $48.70 | Feb 19, 2015 | M | 15,401 | D | Oct 30, 2007 | Oct 30, 2016 | Ordinary Shares | 15,401 | 0 | D |
Explanation of responses
- F1These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.145 to $78.42, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.50, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.